(Q40323661)

19 September 2017

A novel dendritic cell subset involved in tumor immunosurveillance (English)

1 reference

19 September 2017

1 reference

15

1 reference

19 September 2017

24

1 reference

19 September 2017

23

Bernard Ryffel

0 references

François Ghiringhelli

16

François Ghiringhelli

0 references

Thomas Tursz

20

Thomas Tursz

0 references

Lionel Apetoh

4

Lionel Apetoh

0 references

Laurence Zitvogel

25

Laurence Zitvogel

0 references

Caroline Flament

10

Caroline Flament

0 references

François Martin

17

François Martin

0 references

Magali Terme

9

Magali Terme

1 reference

19 September 2017

2

Nathalie Chaput

0 references

Graça Raposo

21

Graça Raposo

1 reference

19 September 2017

1

Julien Taieb

1 reference

19 September 2017

Evelyn Ullrich

5

0 references

Elena Tomasello

Elena Tomasello

14

0 references

David Klatzmann

David Klatzmann

18

0 references

Thierry Poynard

Thierry Poynard

19

0 references

Paule Opolon

11

Paule Opolon

1 reference

19 September 2017

3

Cédric Ménard

1 reference

19 September 2017

6

Mathieu Bonmort

1 reference

19 September 2017

8

Noelia Casares

1 reference

19 September 2017

7

Marie Péquignot

1 reference

19 September 2017

13

Didier Métivier

1 reference

19 September 2017

22

Hideo Yagita

1 reference

19 September 2017

Yann Lecluse

12

1 reference

PubMed ID

16444265

19 September 2017

language of work or name

English

0 references

publication date

29 January 2006

1 reference

19 September 2017

1 reference

19 September 2017

12

1 reference

19 September 2017

214-219

1 reference

19 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1356

19 September 2017

0 references

cites work

Nature's TRAIL--on a path to cancer immunotherapy

1 reference

7 January 2021

TRAIL and its receptors as targets for cancer therapy

1 reference

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

7 January 2021

The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.

1 reference

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

7 January 2021

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

7 January 2021

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

1 reference

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

7 January 2021

IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway

1 reference

7 January 2021

Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow

1 reference

7 January 2021

In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment.

1 reference

7 January 2021

Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation

1 reference

7 January 2021

Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells

1 reference

7 January 2021

Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells

1 reference

7 January 2021

A subset of cytolytic dendritic cells in rat.

1 reference

7 January 2021

CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells

1 reference

7 January 2021

Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets

1 reference

7 January 2021

Measles virus induces functional TRAIL production by human dendritic cells

1 reference

7 January 2021

Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance

1 reference

7 January 2021

Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia

1 reference

7 January 2021

Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme

1 reference

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

7 January 2021

Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1356

1 reference

19 September 2017

1 reference

PubMed ID

16444265